Advertisement

Topics

US Medicare Oncology Demo Should Test Value-Based Drug Pricing – Providers

14:34 EDT 14 Jun 2019 | SCRIP

Community Oncology Alliance proposes updates to the Oncology Care Model demonstration project, including a sharper focus on lowering prescription drug...

      

Related Stories

 

Original Article: US Medicare Oncology Demo Should Test Value-Based Drug Pricing – Providers

NEXT ARTICLE

More From BioPortfolio on "US Medicare Oncology Demo Should Test Value-Based Drug Pricing – Providers"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.

Prescription Drugs
A prescription drug (also prescription medication or prescription medicine) is a licensed medicine that is regulated by legislation to require a medical prescription before it can be obtained. The term is used to distinguish it from over-the-counter drug...